A detailed history of Credit Suisse Ag transactions in X Biotech Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 248,270 shares of XBIT stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
248,270
Previous 248,270 -0.0%
Holding current value
$1.91 Million
Previous $993,000 103.22%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$3.56 - $4.65 $10,680 - $13,950
3,000 Added 1.22%
248,270 $993,000
Q4 2022

Feb 13, 2023

SELL
$3.03 - $3.79 $55,867 - $69,880
-18,438 Reduced 6.99%
245,270 $860,000
Q3 2022

Nov 10, 2022

BUY
$3.58 - $5.88 $134,468 - $220,858
37,561 Added 16.61%
263,708 $955,000
Q2 2022

Aug 12, 2022

BUY
$5.13 - $9.2 $360,608 - $646,704
70,294 Added 45.1%
226,147 $1.27 Million
Q1 2022

May 16, 2022

SELL
$8.64 - $11.71 $1,062 - $1,440
-123 Reduced 0.08%
155,853 $1.35 Million
Q4 2021

Feb 14, 2022

BUY
$10.95 - $16.07 $226,675 - $332,665
20,701 Added 15.3%
155,976 $1.74 Million
Q3 2021

Nov 12, 2021

SELL
$12.95 - $18.24 $284,304 - $400,440
-21,954 Reduced 13.96%
135,275 $1.75 Million
Q2 2021

Aug 16, 2021

BUY
$15.83 - $17.84 $1.31 Million - $1.48 Million
82,976 Added 111.75%
157,229 $2.6 Million
Q1 2021

May 14, 2021

BUY
$15.92 - $20.3 $359,935 - $458,962
22,609 Added 43.78%
74,253 $1.28 Million
Q4 2020

Feb 12, 2021

SELL
$15.65 - $19.92 $10,172 - $12,948
-650 Reduced 1.24%
51,644 $808,000
Q3 2020

Nov 13, 2020

BUY
$13.97 - $21.16 $523,413 - $792,801
37,467 Added 252.69%
52,294 $998,000
Q2 2020

Aug 12, 2020

SELL
$10.39 - $16.07 $261,796 - $404,915
-25,197 Reduced 62.95%
14,827 $202,000
Q1 2020

May 13, 2020

BUY
$8.89 - $24.94 $239,861 - $672,906
26,981 Added 206.86%
40,024 $425,000
Q4 2019

Feb 12, 2020

SELL
$8.33 - $19.95 $3,815 - $9,137
-458 Reduced 3.39%
13,043 $244,000
Q3 2019

Nov 12, 2019

BUY
$6.86 - $10.46 $8,815 - $13,441
1,285 Added 10.52%
13,501 $141,000
Q2 2019

Aug 14, 2019

BUY
$6.99 - $11.27 $85,389 - $137,674
12,216 New
12,216 $92,000
Q1 2019

May 14, 2019

SELL
$5.05 - $11.62 $50,631 - $116,502
-10,026 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$3.22 - $6.27 $44,142 - $85,955
-13,709 Reduced 57.76%
10,026 $51,000
Q3 2018

Nov 13, 2018

SELL
$2.31 - $4.69 $56,553 - $114,820
-24,482 Reduced 50.77%
23,735 $76,000
Q2 2018

Aug 14, 2018

SELL
$4.04 - $5.13 $26,744 - $33,960
-6,620 Reduced 12.07%
48,217 $217,000
Q1 2018

May 15, 2018

SELL
$3.92 - $5.35 $929 - $1,267
-237 Reduced 0.43%
54,837 $293,000
Q4 2017

Feb 14, 2018

SELL
$3.9 - $4.66 $84,532 - $101,005
-21,675 Reduced 28.24%
55,074 $216,000
Q3 2017

Nov 14, 2017

BUY
$4.14 - $5.12 $187,086 - $231,372
45,190 Added 143.19%
76,749 $334,000
Q2 2017

Aug 14, 2017

BUY
N/A
31,559
31,559 $149,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $235M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.